Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

"We'd had some unfortunate health issues in our family, and we were convinced that diet improvements would have made a big ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Rounding off the four units is an arm catering for the world's rich, a key focus for HSBC in Asia and the Middle East. HSBC will also have a new geographic split between "Eastern markets" in Asia ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases ...